Nirmatrelvir-ritonivir, COVID-19, and possible adverse cutaneous reactions. Albrecht JM, Cooper BR, Waller JD, Presley CL, et al. Dermatol Online J 2023;29.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Albrecht JM, Cooper BR, Waller JD, Presley CL, et al. Nirmatrelvir-ritonivir, COVID-19, and possible adverse cutaneous reactions. Dermatol Online J 2023;29.
PMID: 37040906